<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Is Regulatory Harmonization Between the FDA and the EMA Decreasing?
Image Overlay - Is Regulatory Harmonization Between the FDA and the EMA Decreasing?

Is Regulatory Harmonization Between the FDA and the EMA Decreasing?

September 11, 2019

Is Regulatory Harmonization Between the FDA and the EMA Decreasing?

Although the two agencies have historically agreed on over 90% of new drug approvals, a new study conducted by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) suggests that the EMA may be less likely to approve new drugs than the FDA. Regulatory harmonization is a critical concern for Yourway’s customers engaged in international clinical trials.

 Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Clinical Trial Supply Europe

February 24-26, 2026
Hyatt Regency, Barcelona Tower

Global Clinical Supplies Group Asia Pacific Conference

March 10-12, 2026
Conrad Seoul Hotel, South Korea

Media

Articles

Why Integration Matters in Clinical Supply Chains

Open chat
Come chat with us!
Hello! How can I help you?